BMPR1B Knockout HEK293 Cell Line
Cat.No.:
EDC07612
Species:
Human
Cell Name:
HEK293
Gene:
BMPR1B
Gene ID:
658
Size:
1×10⁶cells
BMPR1B Knockout HEK293 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07612 |
|---|---|
| Product Name | BMPR1B Knockout HEK293 Cell Line |
| Species | Human |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Gene ID | |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | BMPR1B |
| Gene Synonyms | ALK-6|ALK6|AMD3|AMDD|BDA1D|BDA2|CDw293 |
| Summary |
This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
|
| Digestion Time | ~1 min |
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying BMPR1B function, BMPR1B Knockout HEK293 Cell Line or BMPR1B overexpression HEK293 Cell Line?
The choice depends on whether you are studying BMPR1B (ALK6)'s role as a type I BMP receptor or modeling its functions in cartilage biology and emerging cancer applications. The Knockout line is the standard tool for asking whether BMPR1B is required for BMP signaling — BMPR1B is a type I serine/threonine kinase receptor for BMPs (especially BMP2, BMP4, BMP7, GDF5) that, upon ligand binding, recruits type II receptor (BMPR2) and phosphorylates SMAD1/5/8 transcription factors. BMPR1B is critical for cartilage/skeletal development. Overexpression is useful for studying BMPR1B gain-of-function effects.
For BMP signaling research, the EDITGENE BMPR1B Knockout in HEK293 is a workhorse mechanistic platform — HEK293 supports systematic structure-function studies. This product complements the parallel BMPR1B Knockout in HAP1 (also available) for cross-background validation. BMPR1B mutations cause brachydactyly type A2 and acromesomelic dysplasia. Rescue with wild-type or kinase-dead BMPR1B enables structure-function studies. The knockout is valuable for studying BMP-SMAD signaling and emerging BMPR1B-targeted approaches.
What are the application scenarios for this model?
Primary applications:
• BMP-SMAD signaling: BMP2/BMP4/BMP7-induced phospho-SMAD1/5/8 analysis in BMPR1B-null cells.
• Skeletal dysplasia modeling: rescue with patient-derived BMPR1B mutations for brachydactyly type A2 and acromesomelic dysplasia studies.
• ALK6 inhibitor specificity: emerging BMPR1B-selective inhibitors specificity testing.
• Cross-background validation: parallel analysis with BMPR1B KO in HAP1 (also available).
EDITGENE recommends this HEK293-based model for systematic BMPR1B biochemistry and skeletal dysplasia disease modeling.
Is this BMPR1B Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. BMPR1B rescue experiments are well-established for BMP signaling research:
• Construct design: use a codon-modified BMPR1B sequence with a small intracellular C-terminal tag (FLAG, HA). BMPR1B has extracellular ligand-binding region, single transmembrane span, GS domain (type II receptor phosphorylation site), and intracellular kinase domain — preserve all elements.
• Surface localization validation: confirm plasma membrane localization before BMP binding studies.
• Kinase-dead rescue: K231R mutation in the ATP-binding lysine abolishes catalytic activity.
• Constitutively-active rescue: Q203D mutation in the GS domain generates constitutively active BMPR1B.
• Functional readout: rescue should restore BMP-induced phospho-SMAD1/5/8 signaling.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download